IMMUNOMAX
- Registration number:P N001919/02
- Pharmaceutical form:lyophilizate for solution for intramuscular injection
- Pharmacotherapeutic group:immunomodulatory agent
- Dosage form:Lyophilizate for solution for intramuscular injection. 100 U or 200 U in a vial or an ampoule.
- Composition:Immunomax 100 U; 200 U. Sodium chloride 8.1 mg; 7.2 mg.
IMMUNOMAX – enhances the immune protection against viral and bacterial infections.
- Indications for use:
-
- Correction of compromised immunity;
- Treatment of pathologic conditions (condylomas, verrucas, dysplasia, etc.) caused by human papillomavirus;
- Treatment of infections caused by herpes simplex virus, chlamydia, mycoplasma, ureaplasma, and other bacteria and viruses.
- Method of administration and posology:
-
Before use, dissolve the medicinal product in 1 mL of water for injection.
- Shelf life:
-
2 years. Do not use after the expiry date.
- Manufacturer:
- IMMAPHARMA, LLC
Recommended dose for adults and children aged 12 years old and over is 100-200 U depending on the disease severity.
The medicinal product is injected intramuscularly once daily.
Treatment course – 6 injections on treatment days 1, 2, 3, 8, 9, 10.
We recommend
-
-
-
Spasmolytic agent
-
Enzyme product
-
-
Sedating medication
-
Antifungal agent
-
Calcium channel blocker
-
Antimicrobial agent
-
Antimicrobial agent
-
Antimicrobial and antiprotozoal agent
-
Potassium and magnesium preparation
-
-
Metabolic agent
-
Non-steroidal anti-inflammatory drug (NSAID)
-
antiviral agent, aciclovir
-
-
Antimicrobial agent
-
Antimicrobial agent
-
Combination drug
-
Enterosorbent.
-
Antiviral drug
-
Analgesic agent
-
Antifungal agents
-
Combination antimicrobial agent
-
Antifungal agent
-
-
Coronary dilating drug
-
Vitamin preparation
-
Antimicrobial and antiprotozoal agent.
-
Combination drug
-
NOBAZIT®
-
Antiepileptic agent
-
Antimicrobial agent
-